Compliance of patients with essential hypertension treated with Candesartan or Candesartan/hydrochlorothiazide - CoCa

Study identifier:NIS-CGE-ATA-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Compliance of patients with essential hypertension treated with Candesartan or Candesartan/hydrochlorothiazide

Medical condition

essential hypertension

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Unmapped

Actual Enrollment

1773

Study type

Observational

Age

None - None

Date

Study Start Date: 01 Jan 2007
Primary Completion Date: -
Study Completion Date: 01 Sept 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2008 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria